Aarti Drugs Limited — Updates, 07-03-2026: General Updates
07-03-2026 | 01:11 pm
07-03-2026 | 01:11 pm
Aarti Drugs invests ₹10 Cr in its wholly-owned subsidiary, Pinnacle Life Science, to fund expansion and capex plans. Pinnacle, a pharmaceutical manufacturer, reported an FY25 turnover of ₹253.92 Cr. This capital infusion aims to boost future growth.
No comments yet. Be the first to comment!
